HIV-1 Escape from the CCR5 Antagonist Maraviroc Associated with an Altered and Less-Efficient Mechanism of gp120-CCR5 Engagement That Attenuates Macrophage Tropism

Maraviroc (MVC) inhibits the entry of human immunodeficiency virus type 1 (HIV-1) by binding to and modifying the conformation of the CCR5 extracellular loops (ECLs). Resistance to MVC results from alterations in the HIV-1 gp120 envelope glycoproteins (Env) enabling recognition of the drug-bound con...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Roche, Michael, Jakobsen, Martin R., Sterjovski, Jasminka, Ellett, Anne, Posta, Filippo, Lee, Benhur, Jubb, Becky, Westby, Mike, Lewin, Sharon R., Ramsland, Paul A., Churchill, Melissa J., Gorry, Paul R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2011
Assuntos:
Virus-Cell Interactions
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3126252/
https://ncbi.nlm.nih.gov/pubmed/21345957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00106-11
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados